首页 | 本学科首页   官方微博 | 高级检索  
     


Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
Authors:Watson Douglas S  Endsley Aaron N  Huang Leaf
Affiliation:Biosciences Division, SRI International, 140 Research Drive, Harrisonburg, VA 22802, United States. watson.douglas@gmail.com [corrected].
Abstract:Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for induction of antibody and T lymphocyte responses to associated subunit antigens. In the last 15 years, liposome vaccine technology has matured and now several vaccines containing liposome-based adjuvants have been approved for human use or have reached late stages of clinical evaluation. Given the intensifying interest in liposome-based vaccines, it is important to understand precisely how liposomes interact with the immune system and stimulate immunity. It has become clear that the physicochemical properties of liposomal vaccines - method of antigen attachment, lipid composition, bilayer fluidity, particle charge, and other properties - exert dramatic effects on the resulting immune response. Here, we present a comprehensive review of the physicochemical properties of liposomal vaccines and how they influence immune responses. A discussion of novel and emerging immunomodulators that are suitable for inclusion in liposomal vaccines is also presented. Through a comprehensive analysis of the body of liposomal vaccine literature, we enumerate a series of principles that can guide the rational design of liposomal vaccines to elicit immune responses of a desired magnitude and quality. We also identify major unanswered questions in the field, pointing the direction for future study.
Keywords:111In-DTPA, 111In-labeled diethylenetriaminepentaacetic acid   APC, antigen presenting cell   ATRA, all-trans retinoic acid   BCR, B cell receptor   BSA, bovine serum albumin   CCS, ceramide carbamoyl-spermine   Chol, cholesterol   CLR, C-type lectin receptor   CpG, unmethylated cytosine-phosphate-guanine motifs   CTL, cytotoxic T lymphocyte   DC-Chol, 3β-[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol   DC-SIGN, dendritic cell-specific intracellular adhesion molecule-3-grabbing non-integrin   DCP, dicetylphosphate   DDA, dimethyldioctadecylammonium   DLiPC, 1,2-dilinoleoyl-sn-glycero-3-phosphocholine   DLPC, 1,2-dilauryl-sn-glycero-3-phosphocholine   DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine   DNP, dinitrophenyl   DNP-Cap-PE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]hexanoyl]   DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine   DOTAP, 1,2-dioleoyl-3-trimethylammonium propane   DOTIM, 1-[2-(oleoyloxy)ethyl]-2-oleyl-3-(2-hydroxyethyl)imidazolinium   DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine   DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine   DPyPE, 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine   DRV, dehydration-rehydration vesicle   DSPC, 1,2-distearoyl-sn-glycero-3-phosphocholine   DSS, disuccinimidyl suberate   DTH, Delayed-type hypersensitivity   EMCS, N-(?-Maleimidocaproyloxy)succinimide   EPC, 1,2-diacyl-sn-glycero-3-phosphocholine from egg   EPG, 1,2-diacyl-sn-glycero-3-phosphoglycerol from egg   ER, Endoplasmic reticulum   GAP-DMORIE, N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(cis-9-tetradeceneyloxy)-1-propanaminium   GCSA, gross cell surface antigen   GMS, glyceryl monostearate   IFN-γ, interferon gamma   IL-12, interleukin 12   LPA, Lysophosphatidic acid   LPC, lysophosphatidylcholine   LPD, lipid–protamine–DNA nanoparticle   LPS, lipopolysaccharide   MDP, muramyl dipeptide   MHC, major histocompatibility complex   MLV, multilamellar vesicle   MPG, 2-monopalmitoylglycerol   MPL, monophosphoryl lipid A   NLR, NOD-like receptor   NTA, nitrilotriacetic acid   ODA, octadecanoic acid   OVA, ovalbumin   PA, palmitic acid   PC, 1,2-diacyl-sn-glycero-3-phosphocholine   PEG, poly(ethylene glycol)   PG, 1,2-diacyl-sn-glycero-3-phosphoglycerol   PLiPC, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine   poly(I:C), polyinosinic:polycytidylic acid   PRR, pattern recognition receptor   PS, 1,2-diacyl-sn-glycero-3-phosphoserine   QS21, Quillaja saponaria Molina saponin   REV, reverse phase evaporation vesicle   SA, stearylamine   SMS, sorbitan monostearate   SP1, sphingosine-1-phosphate   T20, Polyoxyethylene(20) sorbitan monolaurate   SPDP, (N-succinimidyl-3-(2-pyridyldithio)-propionate)   TAP, transporter associated with antigen processing   TDB, α,α-trehalose-6,6′-dibehenate   TGF-β, transforming growth factor beta   TH1, T helper type 1   TH17, T helper type 17   TH2, T helper type 2   TH9, T helper type 9   TLR, Toll-like receptor   Treg, T regulatory
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号